---
title: "Novo Chairman Lars Rebien Sorensen to Address Investors Following Boardroom Changes"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/280569918.md"
description: "Novo's Chairman Lars Rebien Sorensen will address investors at the annual meeting on Thursday, marking his first appearance since recent boardroom changes. The meeting aims to discuss the company's future direction and address investor concerns following the leadership transition."
datetime: "2026-03-26T05:28:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/280569918.md)
  - [en](https://longbridge.com/en/news/280569918.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/280569918.md)
---

# Novo Chairman Lars Rebien Sorensen to Address Investors Following Boardroom Changes

Novo's Chairman Lars Rebien Sorensen is set to meet with investors at the company's annual meeting on Thursday. Bloomberg posted on X that this will be Sorensen's first appearance before investors since the recent boardroom upheaval. The meeting is anticipated to address the changes and future direction of the company. Investors are keen to hear Sorensen's insights and plans following the leadership transition.

### Related Stocks

- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)

## Related News & Research

- [Novo Nordisk Shares Rise After Positive Oral Semaglutide Trial In Children](https://longbridge.com/en/news/284013692.md)
- [Woodside Energy AGM Address by Chair Richard Goyder and CEO Liz Westcott | WDS Stock News](https://longbridge.com/en/news/283751393.md)
- [Novo Nordisk's new weight-loss pill meets main goal in late-stage diabetes study](https://longbridge.com/en/news/283801891.md)
- [Novo Nordisk Expands Workforce After Deep Cuts](https://longbridge.com/en/news/283036289.md)
- [Novo Nordisk Wins FDA Nod for First Once‑Weekly Basal Insulin Awiqli in U.S.](https://longbridge.com/en/news/280789111.md)